KERATINOUS MATERIAL CARE COMPOSITION
The biphasic composition with a thiopyridinone compound in the aqueous phase and oil-soluble agents in the oily phase, stabilized by hydrophobic particles, addresses stability issues of oil- and water-soluble agents, enhancing their performance and longevity in cosmetic applications.
Patent Information
- Application Number
- FR2023006271
- Authority / Receiving Office
- FR · FR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-16
- Filing Date
- 2023-06-19
- Publication Date
- 2024-11-22
AI Technical Summary
Existing cosmetic compositions containing oil- and water-soluble/dispersible active agents face stability issues, particularly when exposed to elevated temperatures, leading to destabilization and reduced efficacy.
A biphasic composition is developed, comprising a continuous aqueous phase with thiopyridinone compounds and an oily phase with oil-soluble active agents, stabilized by hydrophobic particles at the interface, ensuring both phases remain separate and enhance stability.
The biphasic composition effectively maintains the stability and efficacy of both oil- and water-soluble active agents, even under elevated temperatures, improving the overall performance and longevity of cosmetic benefits.
Abstract
Description
Title of the invention: COMPOSITION FOR CARE OF KERATINOUS MATERIALS Technical field
[0001] The present invention relates to a composition, preferably for the care of keratinous materials, and in particular the skin. Furthermore, the present invention relates to the use of this same composition for the care of keratinous materials, in particular the skin. CONTEXT
[0002] The ultimate goal of the cosmetics field has always been to deliver products with skin benefits such as anti-aging, moisturizing, whitening, cleansing, and others.
[0003] Some oil-soluble / dispersible active agents are generally more stable in the undissolved / undispersed state, e.g., in dry form, compared to their aqueous solution, thus affecting their cosmetic effect.
[0004] It is known, particularly in the food and pharmaceutical field, to formulate these types of ingredients in dry form, such as beads, granules, particles, tablets, etc., or in a very sticky form, such as cream, rich lotion, etc. For example, traditional cosmetic compositions with a high retinol content are usually prepared as a cream or rich lotion, as these systems are usually easy to use to improve the stability of the retinol in the formula. On the other hand, these formulas are very rich and greasy for the skin.
[0005] In addition, some water-soluble / dispersible active agents are also more stable in the undissolved / undispersed state. For example, it is known that some thiopyridinone compounds exhibit good depigmenting activity even at low concentrations. However, it has been discovered that a thiopyridinone compound tends to destabilize in a composition over time, particularly when the composition including the thiopyridinone compound is maintained for a relatively long period at an elevated temperature.
[0006] Therefore, when both oil- and water-soluble / dispersible active agents, which are more stable in dry form, are to be applied simultaneously, there is a need for a new type of composition for caring for keratinous materials, particularly skin, for increased stability of both oil- and water-soluble / dispersible active agents over time. Summary of the invention
[0007] Therefore, in one aspect, it is preferable to provide a composition, preferably potentially for the care of keratinous materials in order to simultaneously distribute soluble / dispersible active agents in both oil and water with desirable stability.
[0008] In another aspect, it is preferable to provide a composition, preferably for the care of keratinous materials, in particular the skin, with improved ease of use.
[0009] An object of the invention is therefore to propose a two-phase composition comprising: A. a continuous aqueous phase comprising at least one thiopyridinone compound or its derivative; B. an oily phase comprising at least one oil-soluble / dispersible active agent; and C. hydrophobic particles made to adhere to the surface of the oily phase.
[0010] The expression "hydrophobic particles made to adhere to the surface of the oily phase" means that the two-phase composition is stabilized by hydrophobic particles which absorb onto the interface between the aqueous phase and the oily phase to separate the oily phase from the aqueous phase.
[0011] The thiopyridinone compound useful in the aqueous continuous phase A) is a compound of formula (I) and (!') or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or in mixture; O
[0012] Formulas (I) and (!') in which:
[0013] Ri denotes a radical chosen from: a. a hydrogen atom; b. a linear or branched C1-C10 saturated alkyl group optionally substituted by one or more groups, which may be the same or different, chosen from:
[0014] i) -O-R3
[0015] ii)-S-R3;
[0016] R2 denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C12 or branched C3-C12 or cyclic C3-C8 saturated hydrocarbon group, optionally substituted by one or more groups, which may be the same or different, chosen from: i. -O-R3 ii. -S-R3 iii. -C(O)-O-R3 ; iv. a C5-C12 aryl group, optionally substituted by one or more hy- droxyls and / or by one or more CrC8 alkoxy radicals; a. a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more C1-C8 alkoxy radicals
[0017] R3 denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C10 or branched C3-C10 saturated alkyl group;
[0018] Compound (I1) is the tautomeric form of compound (I) when a tautomeric equilibrium exists according to the following scheme:
[0019] According to one embodiment of the invention, Ri represents a hydrogen atom.
[0020] According to another embodiment of the invention, Ri represents a linear (C1-C10) or branched (C3-C10) alkyl group, in particular a linear (C1-C6) or branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl. Particularly, said alkyl group of Ri is not substituted.
[0021] According to one embodiment of the invention, R2 represents a hydrogen atom.
[0022] According to another embodiment of the invention, R2 represents a linear (C1-C10) or branched (C3-C10) alkyl group, in particular a linear (C1-C6) or branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably a methyl or ethyl group; said alkyl group of R2 being unsubstituted.
[0023] According to another embodiment of the invention, R2 represents a linear (C1-C10) or branched (C3-C10) alkyl group, in particular a linear (C1-C6) or branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; said alkyl group being substituted by one or more groups chosen from i), ii), iii) and iv) as defined hereinbefore. Preferably, said alkyl group being substituted by one or more groups chosen from i), ii) and iii), more preferably by one or two groups chosen from i) and iii), better substituted by a group iii) such as carboxy.
[0024] Another variant for the radical R2 is that said alkyl group is substituted by a group iv) in particular substituted by a phenyl group.
[0025] According to another embodiment of the invention, R2 represents a cycloalkyl group (C3-C8), preferably a cycloalkyl group (C5-C7) such as cyclohexyl.
[0026] According to another embodiment of the invention, R2 represents a C5-C12 aryl group optionally substituted by one or more hydroxyls and / or by one or more C1-C8 alkoxy radicals, preferably a phenyl group in particular unsubstituted.
[0027] According to one embodiment, R3 represents a hydrogen atom.
[0028] According to another embodiment, R3 represents a linear C1-C10 or branched C3-C10 saturated alkyl group; in particular a linear (C1-C6) alkyl group or a branched (C3-C6) alkyl group, preferably an alkyl group (C1-C4) such as the methyl group.
[0029] The present invention also relates to the use of the composition according to the present invention for the care of keratinous materials, in particular the skin. This use can be manifested by a process for the care of keratinous materials, in particular the skin.
[0030] Other characteristics and advantages of the present invention will appear more clearly on reading the description and examples which follow. MODES OF EMBODIMENT OF THE INVENTION
[0031] Throughout the description, including the claims, the expression "comprising a(n)" must, unless otherwise stated, be understood as being synonymous with "comprising at least one". Furthermore, the expression "at least one" used in the present description is equivalent to the expression "one or more".
[0032] Preferably, the “keratinous material” according to the present invention is the skin. By “skin”, we mean all the skin of the body. Still preferably, the keratinous material is the face, or the neck, in particular the face.
[0033] Apart from the operational examples, or unless otherwise indicated, all numbers expressing amounts of components and / or reaction conditions are to be understood as being modified in all cases by the term "about", with a meaning conventionally known in the art, for example, to within 10% of the number indicated (such as "about 10%" means 9% to 11% and "about 2%" means 1.8% to 2.2%).
[0034] In the application, unless specifically stated otherwise, contents, parts and percentages are expressed on a weight basis.
[0035] For the purposes of the present invention, and unless otherwise indicated:
[0036] a “CrCi2 linear or C3-Ci2 branched saturated hydrocarbon group” is equivalent to a “linear (CrCi2) or branched (C3-Ci2) alkyl group” which corresponds to a linear CrCi2 or branched C3-Ci2 saturated hydrocarbon group, and preferably a linear C1-Cio or branched C3-Cio hydrocarbon-based group, more preferably a linear C1-C6 or branched C3-C6 hydrocarbon-based group; preferably, the linear or branched groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl and decyl.
[0037] More preferably, the linear or branched saturated alkyl groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl and octyl, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl. • a saturated cyclic C3-C8 hydrocarbon group is a monocyclic or bicyclic cycloalkyl group containing from 3 to 8 carbon atoms, is in particular a monocyclic C5-C7 cycloalkyl group such as the cyclohexyl group, • an “alkoxy radical” is an alkyloxy radical for which the alkyl radical is a linear or branched hydrocarbon-based radical in CrCi6 and preferably in CrC8; • when the alkoxy group is optionally substituted, this implies that the alkyl group is optionally substituted as defined above; • an “aryl” group represents a carbon-based group, monocyclic or bicyclic, fused or not, comprising from 5 to 12 carbon atoms, preferably from 6 to 10 carbon atoms, and in which at least one cycle is aromatic; preferably, the aryl radical is a phenyl, biphenyl, naphthyl, more preferably a phenyl group; • the term “at least one” is equivalent to the term “one or more”; and • the term “included” for a concentration range means that the limits of this range are included in the defined range.
[0038] The salts of the compounds of formula (I), (I'), (II), or (II') as defined below include the conventional non-toxic salts of said compounds, such as those formed at from an organic or inorganic acid or from an organic or inorganic base.
[0039] As salts of the compounds of formula (I), (F), (II) or (II'), mention may be made of:
[0040] the salts obtained by addition of the compound of formula (I) or (II) to: • a mineral base, such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate, for example;
[0041] or • an organic base such as a primary, secondary or tertiary alkylamine, for example a triethylamine or butylamine. This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and / or oxygen atoms and may therefore comprise, for example, one or more alcohol functions; in particular, 2-amino-2-methylpropanol, ethanolamine, triethanolamine, 2-dimethylaminopropanol, 2-amino-2-(hydroxymethyl)-1,3-propanediol and 3-(dimethylamino)propylamine may be mentioned.
[0042] Mention may also be made of amino acid salts, for example lysine, arginine, guanidine, glutamic acid and aspartic acid. Advantageously, the salts of the compounds of formula (I) or (II) (when they comprise a carboxy group) may be chosen from alkali or alkaline earth metal salts such as sodium, potassium, calcium or magnesium salts and ammonium salts. • An "organic or inorganic acid salt" is more particularly chosen from the salts chosen from a salt derived from i) hydrochloric acid HCl, ii) hydrobromic acid HBr, iii) sulfuric acid H2SO4, iv) alkylsulfonic acids: Alk-S(O)2OH such as methanesulfonic acid and ethanesulfonic acid; v) arylsulfonic acids: Ar-S(O)2OH such as benzenesulfonic acid and toluenesulfonic acid; vi) citric acid; vii) succinic acid; viii) tartaric acid; ix) lactic acid; x) alkoxysulfinic acids: Alk-OS(O)OH such as methoxysulfinic acid and ethoxysulfinic acid; xi) aryloxysulfinic acids such as tolueneoxysulfinic acid and phenoxysulfinic acid; xii) phosphoric acid H3PO4; xiii) acetic acid CH3C(O)OH; xiv) triflic acid CF3SO3H; and xv) tetrafluoroboric acid HBF4; • Acceptable solvates of the compounds described in the present invention include conventional solvates such as those formed during the preparation of said compounds due to the presence of solvents. Examples include solvates due to the presence of water or linear or branched alcohols, such as ethanol or isopropanol. • Optical isomers are in particular enantiomers and diastereoisomers.
[0043] The present invention provides a two-phase composition comprising: A. a continuous aqueous phase comprising at least one thiopyridinone compound of formula (I) or (!), or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or as a mixture; A. an oil phase comprising at least one oil-soluble / dispersible active agent; and B. hydrophobic particles made to adhere to the surface of the oil phase. Continuous aqueous phase A)
[0044] The two-phase composition according to the present invention comprises a continuous aqueous phase.
[0045] The continuous aqueous phase comprises water.
[0046] The aqueous phase may also comprise water-miscible organic solvents (at room temperature: 20 to 25°C), for example monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or isopropanol; polyols, containing in particular from 2 to 20 carbon atoms, preferably containing from 2 to 10 carbon atoms and preferably containing from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol; glycol ethers (containing in particular from 3 to 16 carbon atoms) such as mono-, di- or tripropylene glycol (Ci-C4)alkyl ethers, mono-, di- or triethylene glycol (Ci-C4)alkyl ethers and mixtures thereof.
[0047] The aqueous phase may also comprise any water-soluble or water-dispersible compound that is compatible with an aqueous phase, such as hydrophilic gelling agents, chelating agents, an antioxidant, preservatives or surfactants, and mixtures thereof.
[0048] A specific chelating agent may be particularly useful for reducing electrostatic binding associated with a significant presence of water, upon chelation of these ions, the ionic strength of the water decreases. For the purposes of the present invention, for example, in particular the desired stability, ethylenediamine trisodium disuccinate may be provided as an example of a chelating agent.
[0049] Similarly, a specific antioxidant may be particularly useful for the purposes of the present invention, for example, for improved stability of the thiopyridinone compound of formula (I) or (P) in aqueous phase A) and / or of the oil-soluble / dispersible active agent in oily phase B). For this purpose, pentaerythrityl tetra-di-t-butylhydroxyhydrocinnamate may be provided as an example of an antioxidant.
[0050] In particular, the biphasic composition of the present invention may comprise the continuous aqueous phase in an amount ranging from 65% to 99% by weight, in particular from 70% to 90% by weight and more particularly from 75% to 85% by weight, relative to the total weight of the two-phase composition. Thiopyridinone compound
[0051] The two-phase composition according to the invention comprises, in the continuous aqueous phase A), a thiopyridone compound of formula (I) or (!') below or tautomer (!') below or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or in a mixture, as component a): O (!) (I*)
[0052] Formulas (I) and (!') in which:
[0053] Ri denotes a radical chosen from: a. a hydrogen atom; a. a linear or branched C3-C10 saturated alkyl group optionally substituted by one or more groups, which may be the same or different, chosen from: i. -O-R3 ii. -S-R3;
[0054] R2 denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C12 or branched C3-C12 saturated hydrocarbon group or C3-C8 cyclic, optionally substituted by one or more groups, which may be the same or different, chosen from: i. -O-R3 ii. -S-R3 iii. -C(O)-O-R3 ;
[0055] iv) a C5-C12 aryl group, optionally substituted with one or more hy- droxyls and / or by one or more CrC8 alkoxy radicals; a. a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more C1-C8 alkoxy radicals
[0056] R3 denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C10 or branched C3-C10 saturated alkyl group;
[0057] Compound (I1) is the tautomeric form of compound (I) when a tautomeric equilibrium exists according to the following scheme: (H (H
[0058] According to one embodiment of the invention, Ri represents a hydrogen atom.
[0059] According to another embodiment of the invention, Ri represents a linear (C1-C10) or branched (C3-C10) alkyl group, in particular a linear (C1-C6) or branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl. Particularly, said alkyl group of Ri is not substituted.
[0060] According to one embodiment of the invention, R2 represents a hydrogen atom.
[0061] According to another embodiment of the invention, R2 represents a linear (C1-C10) or branched (C3-C10) alkyl group, in particular a linear (C1-C6) or branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably a methyl or ethyl group; said alkyl group of R2 being unsubstituted.
[0062] According to another embodiment of the invention, R2 represents a linear (C1-C10) or branched (C3-C10) alkyl group, in particular a linear (C1-C6) or branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; said alkyl group being substituted by one or more groups chosen from i), ii), iii) and iv) as defined hereinbefore. Preferably, said alkyl group being substituted by one or more groups chosen from i), ii) and iii), more preferably by one or two groups chosen from i) and iii), better substituted by a group iii) such as carboxy.
[0063] Another variant for the radical R2 is that said alkyl group is substituted by a group iv) in particular substituted by a phenyl group.
[0064] According to another embodiment of the invention, R2 represents a cycloalkyl group (C3-C8), preferably a cycloalkyl group (C5-C7) such as cyclohexyl.
[0065] According to another embodiment of the invention, R2 represents a C5-C12 aryl group optionally substituted by one or more hydroxyls and / or by one or more C1-C8 alkoxy radicals, preferably a phenyl group in particular unsubstituted.
[0066] According to one embodiment, R3 represents a hydrogen atom.
[0067] According to another embodiment, R3 represents a linear C1-C10 or branched C3-C10 saturated alkyl group; in particular a linear (C1-C6) alkyl group or a branched (C3-C6) alkyl group, preferably an alkyl group (C1-C4) such as the methyl group.
[0068] Preferably, the compounds of formula (I) and the tautomer (!) or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or as a mixture;
[0069] have the following meanings:
[0070] Ri denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C6 or branched C3-C6 saturated alkyl group optionally substituted by one or more groups, which may be the same or different, chosen from: i. -O-R3
[0071] ii)-S-R3;
[0072] preferentially optionally substituted by one or more groups i)
[0073] R2 denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C10 or branched C3-C10 or cyclic C3-C8 such as C5-C6 saturated hydrocarbon group, optionally substituted by one or more groups, which may be the same or different, chosen from: i. -O-R3 ii. -SR-, iii. -C(O)-O-R3 ; iv. a phenyl group optionally substituted by one or more hydroxyls and / or by one or more C1-C4 alkoxy radicals such as methoxy;
[0074] preferentially substituted by one or more groups chosen from i) and iii), preferentially iii) such as carboxy
[0075] R3 denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C6 or branched C3-C6 saturated alkyl group;
[0076] Preferably, the compounds of formula (I) and the tautomer (I1) or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or as a mixture;
[0077] have the following meanings:
[0078] Ri denotes a radical chosen from: a. a hydrogen atom; a. a saturated linear C1-C4 or optionally branched C3-C4 alkyl group substituted by one or more groups, which may be the same or different, chosen from i) -OR3>more preferably unsubstituted;
[0079] R2 denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C10 or branched C3-C10 or cyclic C3-C8 saturated hydrocarbon group such as C5-C6, optionally substituted by one or more groups, which may be the same or different, chosen from: i. -O-R3
[0080] iii) -C(O)-O-R3;
[0081] iv) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more C1-C4 alkoxy radicals;
[0082] R3 denotes a radical chosen from: a. a hydrogen atom; a. a saturated linear C1-C4 or branched C3-C4 alkyl group such as methyl or ethyl.
[0083] Preferably, the compounds of formula (I) and the tautomer (!) or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or as a mixture;
[0084] have the following meanings:
[0085] Ri is a hydrogen atom; and
[0086] R2 denotes a radical chosen from: a. a hydrogen atom; a. a linear C1-C5 or branched C3-C5 or cyclic C3-C8 saturated hydrocarbon group such as C5-C6, substituted by one or more groups, which may be identical or different, chosen from v) -C(O)-O-R3, preferably substituted by a group iii) -C(O)-O-R3;
[0087] R2 is even more preferably a linear saturated C1-C4 or branched C3-C4 hydrocarbon group substituted by a group iii) -C(O)-OR3.
[0088] According to another preferred embodiment, the compounds of formula (I) and the tautomer (!) are chosen from the compounds of formula (II) as well as their tautomers, their salts, and their optical isomers, and their racemates, alone or as a mixture: oo (iii
[0089] Formulae (II) and (II') in which R1 and R3 have the same meaning as for the compounds of formula (I) and (I') and X denotes an alkylene radical -(CH2)n-, n being an integer ranging inclusively from 1 to 10, preferably from 1 to 6, more preferably from 1 to 4, such that 1, preferably R3 represents a hydrogen atom.
[0090] Among the compounds of formula (I), the following compounds are preferentially used, and their tautomer or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or in mixture:
[0091] [Tables 1] No. Structure Nom chemique N° CA S 1 HHN N-êthy)-2-thtoxo-l ,2-d^ydn^jyhdine-3-çMwxWâe.- 91859-75-5 2 x\ y"' ' / / xS / N-méthyi-2-»ddilwaned-řyço3-1 f2 91859-74-4 3 y N- JCty ■ 2-tniOXO- " ,2-dihydropyndine-3- 91859-77-7 4 X X. . X; ■N-benzyk2-thtoxQ-1.2- dmydmp-, f dine-3- 91859-79-9 5 / 7 X ...------v H*----V '? / ........ / \= / \ / % N-phén yî-2-thi.oxo-112-dthydropyndine-3^ 104857-16-1 6 0 XY JL À J || 1 ' H N-cydQhexyl-2Yh1oxo-V dihydropYi^ne-3- 91859-78-8 y ^Âxx.xy''* LX! • N- [2- (4-phnethoxy phenyl) etM-24hioxo-1.2-dthydfGpyddine-3- 923682-88-8 8 À XA r ï ' w à X N- « 2 - méth Ypmpy 1)-2- thtoxo-1,2-ddtiy- d 1100027–79–9 9 and the x>k; .■ x'X .< | ï' V / " ¢-: N-pent^-2-thfòxo-l ,2- dihydropyndine-3-ŒWOîtt- 330667-57-7 10 n. ; YYN -n on y1-2-lhioxo-1.2-dihyaropyridine-90416- 1 11 0 I. ' 's" H M-(2-hyta <yéWX2-thisx&-t2-dlhÿdfspyïjrfiïse-3- 12 G ~ I ZXY V I! 1, L H 2-mercaDlûfflœfeamkle 13 . 1 [i 1 / ....... "''<x 'Y v,. ts • '• (2-Y 3roxvéW)-2-^^^ 1,2-amy &opy ràfee-3- 14 Y^''" X-x vÿ. i h . * «<- À, X X <>• YY ""' Y x N-{23-dWdf&Wî'WÏr 2-thàJXû-U- ■djhydr$P'Y^&-3- 15 „ fi. r ( y ....... N<1 O vhv .. Y Â (X: c YN^(2-WoxM',2-d§hydmpypdis>3^^^ c^opygg^l^ 17 1 J ...to. T" iÇK
[0092] Among these compounds, the following compounds are more particularly preferred:
[0093] [Tables 2] No Structure sr case 1 N-ethyl-2-thæxo-l 2-dshydropÿdcSine-3-carta^ 91859-75-5 2 ZX w N-ïnêîhyb2-^toco-1,2- 91853-74-4 4 "■'x.... X'' '■■K:':;. 1.2- 91853-79-3 6 ; 330667-57-7
[0094] More preferably, among these compounds, the following compounds are more particularly preferred:
[0095] [Tables3] No, Structure Name ttifmiçue N* CAS 1 .ii [Tables 3] 1 6= a ôHj ( N-(;24h®w-1,2-d§hydropy^clrs- 3->'9cartoWi W» R 20 [. 1 H s 3-s hK 2-th*OsO-1 2-dfhydropyôËHn-■ 3-,s •'athcir / tëycme 21 t Q:< H h 32-Èbiax&4,2-dshx'dropv^li^ glycme
[0096] Even more preferably, among these compounds, the following compounds are more particularly preferred:
[0097] [Tables4] No. Stacîure Chemical name CAS No. -7 h 7 dihydfspÿddtn-SYlca^ » ) \ s* .•W / : M ^-[(^^hfoxo-1 2-dshyds opvhdin-3 <icarb wo&wale d 20 1 (y 7" y n-k24hiûkû-1 .3-yçcætoiyljg^q’ne 21 il ch: h dihydrbpyddm-3-y|wbwü giycihe
[0098] In a most preferred embodiment, the compound according to the present invention is the following:
[0099] [Tables5] 28 À Y ” 1 Y:-'' y? 4hioxo-l ..ZHiihydr^ 3-yOca^nyOWcfce
[0100] All compounds can be obtained by a chemical process known to man of the art, from commercially available reagents. For example, the synthesis method disclosed in European patent application EP3 390 363 can be used.
[0101] Compound 20, N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine, which may also be named 3-carboxymethylaminocarbonyl-2-thiopyridinone, is a typical representative of the thiopyridinone compounds useful according to the present invention.
[0102] The thiopyridinone compound (I), (!'), (II) and / or (II1) may be present in an amount ranging for example from 0.01% to 10% by weight, preferably from 0.1% to 2% by weight, in particular from 0.5% to 1% by weight, relative to the total weight of the two-phase composition. Polysaccharide
[0103] The biphasic composition according to the invention may comprise at least one polysaccharide.
[0104] Preferably, the continuous aqueous phase of the composition comprises at least one polysaccharide.
[0105] Preferably, the polysaccharide(s) are of biotechnological origin.
[0106] In particular, these polysaccharides can, where appropriate, be chemically modified to promote their hydrophilic valence.
[0107] As examples of polysaccharides which can be used according to the present invention, mention may in particular be made of: a. seaweed extracts such as carrageenans, alginates and agar-agar, and mixtures thereof. Examples of carrageenans that may be cited include Satiagum UTC30® and UTC10® from the company Degussa; an alginate that may be cited is sodium alginate sold under the name Kelcosol® by the company ISP; a. gums, such as xanthan gum, gellan gum, guar gum and its non-ionic derivatives (hydroxypropyl guar), gum arabic, konjac gum or mannan gum, tragacanth gum, gum ghatti, karaya gum, locust bean gum, agar gum, scleroglucan gums and mixtures thereof; examples that may be mentioned include xanthan gum sold under the name Keltrol ® CG-T by CP Kelco, gellan gum sold under the name Kelcogel ® CG LA by CP Kelco, guar gum sold under the name Jaguar HP 105 ® by Rhodia; mannan gum and konjac gum ® (1% glu-comannan) sold by GfN; b. starches, which are preferentially modified, such as those derived, for example, from cereals such as wheat, corn or rice, from legumes such as white lentil, from tubers such as potato or cassava, tapioca starches; dextrins, such as dextrin extracted from corn under the name Index ® from National Starch Company; Corn Starch B® from Roquette Company; potato starch modified with 2-chloroethylaminodipropionic acid neutralized with sodium hydroxide, sold under the name Structure Solanace ® by National Starch Company; native tapioca starch powder sold under the name Tapioca Pure ® by National Starch Company; c. pectins, d. chitosan and its derivatives, e. polyholosides comprising at least two saccharides, preferably of natural origin, and in particular chosen from: • aldoses such as • pentoses: ribose, arabinose, xylose or apiose, for example, • hexoses: glucose, fucose, mannose or galactose, for example, • ketoses such as fructose, • deoxyoses, such as rhamnose, digitoxose, cymarose or oleandrose, • saccharide derivatives such as uronic acids, e.g. uric acid mannuronic acid, guluronic acid, galacturonic acid or glycuronic acid, or itols, for example mannitol or sorbitol.
[0108] Mention may in particular be made of polyholosides comprising fucose, galactose and galacturonic acid units, and for example a linear sequence of aL-fucose, aD-galactose and galacturonic acid, for example biosaccharide gum-1 sold under the trade name Fucogelâ 1000 PP or Fucogelâ 1.5P by the company Solabia, a. other useful polysaccharides, in particular of biotechnological origin, such as the anionic polysaccharide carrying as a repeating unit a tetrasaccharide composed of L-fucose, D-glucose and glucuronic acid, such as the product bearing the INCI name Biosaccharide Gum-4 sold under the reference Glycofilm 1.5P by the company Solabia, b. and mixtures thereof.
[0109] Preferably, the polysaccharide(s) of the present invention are chosen from: • gums such as xanthan gum or gellan gum; • polyholosides comprising fucose, galactose and galactose acid units turonic, e.g. biosaccharide gum-1 • and their mixtures.
[0110] More preferably, the polysaccharide(s) of the present invention are chosen from xanthan gum, gellan gum and mixtures thereof.
[0111] According to a preferred embodiment, the biphasic composition of the present The invention comprises from 0.0001% to 5% by weight, preferably from 0.001% to 2% by weight, more preferably from 0.01% to 1% by weight of the polysaccharides, relative to the total weight of the two-phase composition. Oily phase B)
[0112] The composition according to the invention may comprise an oily phase B).
[0113] Preferably, the oily phase comprises at least one fatty substance.
[0114] Preferably, the two-phase composition comprises at least one fatty substance.
[0115] The expression "fatty substance" designates organic compounds which are insoluble in water at ordinary temperature (25 °C) and atmospheric pressure (760 mmHg) (solubility less than 5% by weight, preferably 1% by weight and even more preferably 0.1% by weight). They may preferably have in their structure a chain of at least two siloxane groups or at least one hydrocarbon-based chain comprising at least 6 carbon atoms. In addition, fatty substances are generally soluble in organic solvents under the same temperature and pressure conditions, for example chloroform, ethanol, benzene or decamethylcyclopentasiloxane.
[0116] The fatty substances are in particular chosen from fatty alcohols, fatty acid esters, fatty alcohol esters, fatty acid, lower alkanes, non-silicone waxes, oils, in particular non-silicone animal, vegetable, mineral or synthetic oils, and silicone oils.
[0117] For the purposes of the invention, it is recalled that fatty alcohols, fatty acid esters, fatty alcohol esters and fatty acids contain more particularly one or more groups based on linear or branched, saturated or unsaturated hydrocarbons comprising 6 to 30 carbon atoms, which are optionally substituted, in particular by one or more hydroxyl groups (in particular 1 to 4). If they are unsaturated, these compounds may comprise one to three conjugated or non-conjugated carbon-carbon double bonds.
[0118] The fatty alcohols which can be used in the composition of the invention are not oxyalkylenated. They are saturated or unsaturated, linear or branched and comprise from 6 to 30 carbon atoms and more particularly from 8 to 30 carbon atoms. Mention may be made of cetyl alcohol, stearyl alcohol and their mixture (cetylstearyl alcohol), octyldodecanol, 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol, oleyl alcohol or linoleyl alcohol.
[0119] Useful esters are esters of saturated or unsaturated, linear or branched C1-C26 aliphatic mono- or polyacids and of saturated or unsaturated, linear or branched C1-C26 aliphatic mono- or polyalcohols, the total number of carbons in the esters being more particularly greater than or equal to 10.
[0120] Among the monoesters, mention may be made of dihydroabietyl behenate, octyldodecyl behenate, isocetyl behenate, cetyl lactate, C12-C15 alkyl lactate, isostearyl lactate, lauryl lactate, linoleyl lactate, oleyl lactate; (iso)stearyl octanoate; isocetyl octanoate; octyl octanoate; cetyl octanoate; decyl oleate; isocetyl isostearate; isocetyl laurate; isocetyl stearate; isodecyl octanoate; isodecyl oleate; isononyl isononanoate; isostearyl palmitate; methyl acetyl ricinoleate; myristyl stearate; octyl isononanoate; 2-ethylhexyl isononate; octyl palmitate; octyl pelargonate; octyl stearate; octyldodecyl erucate; oleyl erucate;ethyl and isopropyl palmitates, 2-ethylhexyl palmitate, 2-octyldecyl palmitate, alkyl myristates such as isopropyl, butyl, cetyl, 2-octyldodecyl, myristyl, stearyl myristate, hexyl stearate, butyl stearate, isobutyl stearate; dioctyl malate, hexyl laurate, 2-hexyldecyl laurate. ;
[0121] The composition may also comprise, as fatty ester, sugar esters and diesters of C6-C30 and preferably C12-C22 fatty acids. It is recalled that the term "sugar" designates compounds based on oxygenated hydrocarbons containing several alcohol functions, with or without aldehyde or ketone functions, and which comprise at least 4 carbon atoms. These sugars may be monosaccharides, oligosaccharides or polysaccharides.
[0122] Examples of suitable sugars that may be cited include sucrose, glucose, galactose, ribose, fucose, maltose, fructose, mannose, arabinose, xylose and lactose and their derivatives, including alkyl derivatives, such as methyl derivatives, for example methylglucose.
[0123] The sugar esters of fatty acids may be chosen in particular from the group comprising the sugar esters or their mixtures described above and of linear or branched, saturated or unsaturated fatty acids in C6-C30, and preferably in C[2-C 22. If they are unsaturated, these compounds may comprise one to three conjugated or unconjugated carbon-carbon double bonds.
[0124] The esters according to this variant can also be chosen from mono-, di-, tri-, tetraesters and polyesters, and mixtures thereof.
[0125] With regard to the lower alkanes, these alkanes comprise from 6 to 16 carbon atoms and are linear or branched, optionally cyclic. For example, the alkanes may be chosen from hexane and dodecane, isoparaffins such as isohexadecane and isodecane.
[0126] The non-silicone oils which can be used in the composition of the invention can comprise in particular a “hydrocarbon-based oil” (or “hydrocarbon oil” or “hydrocarbon oil”), which designates an oil formed essentially, or even consisting of, carbon and hydrogen atoms, and optionally of oxygen and nitrogen atoms, and containing no silicon atoms.
[0127] Examples of non-silicone oils that may be cited include: • oils based on hydrocarbons of animal origin, such as perhydrosqualene; • hydrocarbon-based oils of vegetable origin such as liquid fatty acid triglycerides containing from 6 to 30 carbon atoms, for example, heptanoic or octanoic acid triglycerides or alternatively, for example, sweet almond oil, sunflower oil, corn oil, soybean oil, cucurbit oil, grape seed oil, sesame seed oil, hazelnut oil, apricot oil, macadamia oil, arara oil, castor oil, avocado oil, jojoba oil, shea butter oil, and caprylic / capric acid triglycerides, for example those sold by the company Stéarineries Dubois or those sold under the names Miglyol® 810, 812 and 818 by the company Dynamit Nobel;
[0128] - hydrocarbon-based oils of mineral or synthetic origin, which are oils based on linear or branched, saturated or unsaturated hydrocarbons with more than 16 carbon atoms, such as liquid paraffins, liquid petroleum jelly, polydecenes and hydrogenated polyisobutenes such as Parleam®.
[0129] The oily phase may consist of, or consist essentially of, oil, for example, hydrocarbon-based oil.
[0130] Advantageously, the two-phase composition of the present composition comprises from 0.1% to 35% by weight, preferably from 0.5% to 25% by weight, and more preferably from 1% to 20% by weight of the fatty substance, relative to the total weight of the two-phase composition. Oil-soluble / dispersible active agent
[0131] The oily phase B) according to the present invention comprises at least one active agent soluble / dispersible in oil.
[0132] Preferably, the oil-soluble / dispersible active agent is selected from the group consisting of retinoids, vitamin D, vitamin E, vitamin K, phenylethyl resorcinol or its derivative, such as an ester or a hydrophobic modification thereof, and mixtures thereof, more preferably the oil-soluble / dispersible active agent is selected from the group consisting of retinoids.
[0133] An active agent is an agent capable of providing a cosmetic effect to a user, in particular to the skin, for example, the face. Such a cosmetic effect may be, for example, anti-aging, whitening and moisturizing.
[0134] Preferably, the retinoid is chosen from retinoic acid, retinol (vitamin A) and its esters, such as retinyl propionate and retinyl acetate, or retinyl palmitate. Preferably, the retinoid is retinol.
[0135] Preferably, the oily phase B) comprises retinol as an oil-soluble / dispersible active agent.
[0136] The biphasic composition of the present invention may comprise at least one oil-soluble / dispersible active agent in an amount ranging from 0.01% to 2.0% by weight, preferably from 0.05% to 0.30% by weight, or preferably from 0.1% to 0.2% by weight, relative to the total weight of the biphasic composition. Hydrophobic particle C)
[0137] The biphasic composition according to the present invention comprises hydrophobic particles. For the purposes of the present invention, hydrophobic particles will adhere to the surface of the oily phase B), so as to reduce the oxidation of the oil-soluble / dispersible active ingredients, for example, the retinoid in the oily phase.
[0138] In comparison, hydrophilic particles can adhere to the surface of the aqueous phase A). Meanwhile, the thiopyridinone compound of formula (I) or its derivative is contained in the aqueous phase A). Nevertheless, without being limited by any known theory, it is surprising to find that when hydrophobic particles are used, compared to hydrophilic particles or amphiphilic particles, e.g., Polysorbate 20, both the thiopyridinone compound of formula (I) or its derivative in the aqueous phase A) and the oil-soluble / dispersible active agent in the oil phase B) can be well protected against oxidation, so as to improve their stability.
[0139] The particles may be mineral or organic and may be in the form of spherical or lamellar particles. The particles are preferably insoluble in the medium, for example, solvent, oil phase, aqueous phase or the like, of the composition according to the invention, even at the melting point of the medium (for example, approximately 100°C).
[0140] In the present patent application, the expression "spherical particles" means particles of spherical or at least approximately spherical shape, and / or a particle having an aspect ratio of about 0.9 to 1.1, for example, about 0.95 to 1.05. For example, one skilled in the art can determine whether a particle is sphere-shaped according to conventional knowledge. In particular, with respect to a given particle, it is within the ordinary skill of those skilled in the art to distinguish the sphere shape from other shapes of plate, rod, powder, strip, irregular shapes or the like.
[0141] The expression "lamellar particles" herein refers to particles in the shape of a parallelepiped (rectangular or square surface), in the shape of a discoid (circular surface) or in the shape of an ellipsoid (oval surface), characterized by three dimensions: a length, a width and a height. In particular, with regard to a given particle, it is within the ordinary skill of those skilled in the art to distinguish the lamellar shape from the other sphere or similar shapes.
[0142] The hydrophobic particles are different from the polysaccharide mentioned above.
[0143] According to the present invention, the hydrophobic particles may be selected from the group consisting of starches, talc, silicone resin powders, hollow hemispherical silicone particles, hydrophobic cellulose and their derivatives, hydrophobic silica, polyamide powders, hydrophobic pigments or any other hydrophobic particle which can be dispersed in aqueous phase.
[0144] Preferably, the hydrophobic particles are chosen from the group consisting of starches, hydrophobic cellulose and their derivatives, hydrophobic silica and their mixtures.
[0145] The starches may be preferentially modified, such as those derived, for example, from cereals such as wheat, corn or rice, from legumes such as white lentil, from tubers such as potato or cassava, from tapioca starches; from dextrins, such as corn dextrins; Corn Starch B ® from the company Roquette; from potato starch modified with 2-chloroethylaminodipropionic acid neutralized with sodium hydroxide, sold under the name Structure Solanace ® by the company National Starch; from native tapioca starch powder sold under the name Tapioca Pure ® by the company National Starch.
[0146] The hydrophobic celluloses and their useful derivatives may be alkyl- or hydroxy-alkylcelluloses. In particular, methylcelluloses, ethyl-celluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses and carboxymethyl-celluloses may be mentioned. Examples that may be cited include hydroxyethylcellulose sold under the name Natrosol™ 250 HHR PC by the company Ashland, or under the name Cellosize™ QP 4400 H by the company Amerchol (Dow Chemical), cetylhydroxyethylcelluloses sold under the names Polysurf 67CS® and Natrosol Plus 330® from Aqualon.
[0147] According to the present invention, the hydrophobic silica may be "hydrophobically modified" silica, which means silica that has undergone lipophilic modification. According to the present invention, lipophilic modification means any organo-modification capable of providing a hydrophobic or lipophilic treatment to the silica. For example, a silica may be treated with a siloxane compound, for example, hydroxydimethylsiloxane (or other silanes, such as silazane, etc.), whereby the silanol group on the surface of the silica and the silanol group of the siloxane compound are condensed. Among others, useful examples of "lipophilically modified" silica can be made from silica silylate available from TOKUYAMA CORPORATION under the name AIRLICA® TL-10 and silica dimethyl silylate available from EVONIK DEGUSSA under the name AEROSIL® R 972.
[0148] More preferably, the hydrophobic particles are chosen from the group consisting of hydrophobic cellulose and its derivatives, hydrophobic silica, and their mixtures, more preferably alkyl- or hydroxyalkylcelluloses such as ethylcellulose, hydrophobic silica and their mixtures.
[0149] Without being limited by any known theory, it is surprising to find that, although hydrophobic particles C) are to be added, it is further preferred that when hydrophobic celluloses or their derivatives are used as hydrophobic particles C), they are added in a relatively smaller amount. In particular, when both oil-soluble and water-soluble / dispersible active agents are to be applied simultaneously, it is believed that a relatively smaller amount of hydrophobic celluloses or their derivatives as hydrophobic particles C) may benefit the stabilities of both, especially the equilibrium between the two.
[0150] Thus, it is preferable that the biphasic composition of the present invention comprises from 0.001% to 0.1% by weight of the hydrophobic particles C), and if they are used, preferably from 0.002% to 0.05% by weight, or preferably from 0.003% to 0.01% by weight of hydrophobic celluloses or their derivatives as hydrophobic particles C), relative to the total weight of the biphasic composition.
[0151] According to a preferred embodiment of the composition of the present invention, the thiopyridinone compound of formula (I) or its derivative is placed in the continuous aqueous phase A) and the oil-soluble / dispersible active agent is placed in the oily phase B). Then, it may be surprising to find that the stability of the entire composition is considerably improved, not only compared to the thiopyridinone compound or the oil-soluble / dispersible active agent alone, but also compared to the simultaneous presence of both the thiopyridinone compound and the oil-soluble / dispersible active agent in the same phase, or simply mixed.In particular, as oil-soluble / water-dispersible substances respectively, component a) can react with oil-soluble / water-dispersible substances when mixed together, for example, N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine (compound 20) with retinol. Composition formation process .
[0152] The process of forming the biphasic composition is not specifically limited, as long as the oil-soluble / dispersible active agent can be uniformly distributed in the oil phase B), while the thiopyridinone compound of formula (I) or its derivative can be uniformly distributed in the continuous aqueous phase A).
[0153] According to the present invention, the hydrophobic particles C) are added into alcohol, for example ethanol to obtain a mixture 1. Then, the mixture 1 is added into the aqueous phase A) to obtain a mixture 2. Subsequently, the mixture 2 is added into the oily phase B) to obtain the composition according to the present invention. When adding, stirring or any other means known in the art facilitating homogeneous mixing may be applied.
[0154] An example process includes the steps of: 1. Addition of hydrophobic particles C) into alcohol, with stirring until the particles are dispersed, to obtain mixture 1. 2. Mixing of the materials for the aqueous phase A) until all the materials are dissolved / dispersed, to obtain the aqueous phase A). 3. Adding mixture 1 to phase A), with stirring until uniform, to obtain mixture 2. 4. Mixing of the materials for the oil phase B), with stirring until all the materials are dissolved, to obtain the oil phase B). 5. Addition of mixture 2 to the oil phase B), with stirring for 30 to 40 seconds.
[0155] Following the process according to the present invention, in the composition obtained, the oily phase can be dispersed in water or underwater.
[0156] The composition of the present invention may be used for a non-therapeutic process, such as a cosmetic process or method, for making up / caring for a keratinous material, such as skin, by being applied to the skin.
[0157] The invention will be further illustrated by the following Examples, which present particularly advantageous embodiments. EXAMPLES
[0158] The quantities / concentrations of the ingredients in the compositions / formulas described below are expressed in % by weight, relative to the total weight of each composition / formula.
[0159] Compounds are listed with their chemical name or INCI name.
[0160] [Tableauxô] INCI name Trade name Supplier RETINOL RETINOL 10SU BASF ACETYL TRIBUTYL CITRATE CITROFLEX A4 VERTELLUS PENTAERYTHRITYL TETRA-DLT-BUTYL HYDROXYHY- DROCINNAMATE TINOGARD TT BASF TRISODIUM ETHYLENEDIAMINE DISUCCINATE NATRLQUEST E30 INNOSPEC ACTIVE CHEMICALS Xanthan Gum KELTROL®CG-T CP KELCO GELLAN GUM KELCOGEL® CG LA CP KELCO Example A
[0161] The inventive compositions of Ex.1 and Ex.2, as well as the comparative compositions of EC.1 to EC.5, were prepared as follows.
[0162] [Tables?] Components Ex. 1 Ex. 2 Ex. 3 EC. 1 EC.3 EC. 4 Phase A WATER QS QS QS QS QS QS ALCOHOL 5 5 5 5 5 5 GELLAN GUM 0.085 0.085 0 0 0 0 XANTHAN GUM 0.085 0.085 0 0 0 0 N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl] glycine (Compound 20) 0.5 0.5 0.5 0.5 0.5 0.5 TRISODIUM ETHYLENEDIAMINE DISUCCINATE 0.2 0.2 0.2 0.2 0.2 0.2 PEG-60 ALMOND GLYCERIDES 0 0 0 0 0.5 0 POLYSORBATE 20 (amphiphilic) 0.3 CHLORIDE CALCIUM 0.5 0.5 0.5 0.5 0.5 0.5 Phase B TRIBUTYL ACETYL CITRATE 3 3 3 3 3 3 RETINOL 0.1 0.1 0.1 0.1 0.1 0.1 PENTAERYTHRITYL TETRA-DLT-BUTYL HY-DROXYHYDROCINNAMA TE 0.3 0.3 0.3 0.3 0.3 0.3 Other ETHYLCELLULOSE 0.003 0 0 0 0 0 Silica dimethylsilylate 0 0.1 0.1 0 0 0
[0163] Preparation protocol using the compositions in Table 7: 1. Mix tributyl acetyl citrate and pentaerythrityl tetra-di-t-butyl hydroxyhydro-cinnamate phase B in container 1, stir and heat to 80°C to completely dissolve the materials, cool to 25°C, then add retinol to container 1 to obtain mixture 1; and 1. Mix the materials of phase A in container 2, heat to 80°C to completely dissolve the materials, then cool to 25°C; 2. Add other materials (e.g., ethylcellulose) to container 2 to obtain a mixture 2, stir until all materials are well mixed; 3. Add Mix 1 into Mix 2, mixing at 300 rpm for 5 min.
[0164] II. Evaluation of the inventive compositions and comparative examples
[0165] The inventive compositions and comparative examples were evaluated using the following protocols.
[0166] Method for evaluating texture transformation
[0167] The contents of oil-soluble / dispersible active agent, i.e., retinol and N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine (compound 20) of all samples of the inventive compositions and comparative compositions over time were evaluated via the HPLC system for T0 (immediately after preparation) and T2M (two months after preparation). Specifically, after preparation, all samples were divided into two equal parts, for which the first half-parts were tested for the contents of oil-soluble / dispersible active agent, i.e., retinol and N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine (compound 20) at T0, while the second half-parts were stored under 45 °C for two months. At T2M, the second half-parts were tested for the contents of retinol and N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine (compound 20).
[0168] After HPLC analysis, the exact data of retinol content were finally obtained, as shown in Table 8 below.
[0169] [Tables8] Ex. 1 Ex. 2 Ex.3 EC.1 EC.3 EC.4 Retinol / TO 0.10 0.10 0.10 0.10 0.10 0.10 Retinol / T2M 45°C 0.10 0.09 0.09 0.05 0.03 0.02 Retinol loss from T0 0% 10% 10% 50% 70% 80% N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine (Compound 20) / T0 0.50 0.50 0.50 0.50 0.50 0.50 N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine (Compound 20) / T2M 45°C 0.46 0.45 0.45 0.41 0.22 0.19 Loss of N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glyc ine (Compound 20) relative to T0 8% 10% 10% 18% 56% 62%
[0170] Comparing EX. 3 and EC. 1, it can be seen that EX.3 was formed with a special emulsion comprising hydrophobic particles and stabilizing compounds. The results showed that such a specific emulsion really protected the oil-soluble / dispersible active agent, i.e., retinol in the oil phase. The stability of retinol in Ex.3 was better than that of EC.1.
[0171] Similarly, EC.3 represented the case of the oil-soluble / dispersible active agent, i.e., retinol and N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine (compound 20) in a conventional emulsion system, EC.4 represented the case of the oil-soluble / dispersible active agent, i.e., retinol and N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine (compound 20) in a water-oil biphasic (with the added amphiphilic particles), Ex.1 to 3 according to the present invention showed a surprisingly improved stability considering the oil-soluble / dispersible active agent, i.e., retinol and / or N-[(2-thioxo-l,2-dihydropyridin-3-yl)carbonyl]glycine (compound 20) compared to comparative examples.
[0172] All publications, patents, and patent applications cited in this specification are hereby incorporated by reference, and for all purposes, as if each publication, patent, or patent application were specifically and individually indicated as being incorporated by reference. In the event of any inconsistencies, this disclosure shall prevail.< / icarb>
Claims
Claims
1. A two-phase composition comprising: A) a continuous aqueous phase comprising a component a): a thiopyridine compound of formula (I) or (!'), or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or in mixture; Formulas (I) and (I') in which: - Ri designates a radical chosen from: a) a hydrogen atom; (b) a linear or branched C1-C10 saturated alkyl group optionally substituted by one or more groups, which may be the same or different, chosen from: i) -O-R3 ii) -S-R3; - R2 designates a radical chosen from: a) a hydrogen atom; (b) a linear C1-C12 or branched C3-C12 or cyclic C3-C8 saturated hydrocarbon group, optionally substituted by one or more groups, which may be the same or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more Cr-C8 alkoxy radicals (c) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more C1-C8 alkoxy radicals - R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group; B) an oily phase comprising at least one soluble active agent / dispersible in oil; and C) hydrophobic particles made to adhere to the surface of the oil phase.
2. Two-phase composition according to claim 1, in which: - Ri of formula (I) and (I1) represents a hydrogen atom, or - Ri of formula (I) and (I1) represents a linear (C1-C10) or branched (C3-C10) alkyl group, in particular a linear (C1-C6) or branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl, in particular said alkyl group of Ri is not substituted.
3. Two-phase composition according to claim 1 or 2, in which: - R2 of formula (I) and (I1) represents a linear (C1-C10) or branched (C3-C10) alkyl group, in particular a linear (C1-C6) or branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; said alkyl group being substituted by one or more groups chosen from i), ii), iii) and iv) as defined in claim 1, preferably said alkyl group being substituted by one or two groups chosen from i), ii) and iii), more preferably by one or two groups chosen from i) and iii), better substituted by a group iii) such as carboxy.
4. Two-phase composition according to any one of the preceding claims, in which: - R3 of formula (I) and (I1) represents a hydrogen atom; or - R3 of formula (I) and (P) represents a linear saturated C1-C10 or branched C3-C10 alkyl group; in particular a linear (C1-C6) alkyl group or a branched (C3-C6) alkyl group, preferably a (C1-C4) alkyl group such as a methyl group.
5. Biphasic composition according to any one of the preceding claims, in which: - R 1 of formula (I) and (P) represents a radical chosen from: a) a hydrogen atom; b) a linear C 1 -C 6 or branched C 3 -C 6 saturated alkyl group optionally substituted by one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3; preferentially optionally substituted by one or more groups i) - R2 of formula (I) and (!') represents a radical chosen from a) a hydrogen atom; (b) a linear C1-C10 or branched C3-C10 or cyclic C3-C8 such as C5-C6 saturated hydrocarbon group, optionally substituted by one or more groups, which may be the same or different, chosen from: i) -O-R3 ii) -SR-, iii) -C(O)-O-R3 ; iv) a phenyl group optionally substituted by one or more hydroxyls and / or by one or more C1-C4 alkoxy radicals such as methoxy; preferentially substituted by one or more groups chosen from i) and iii), preferentially iii) such as carboxy - R3 of formula (I) and (!') represents a radical chosen from: a) a hydrogen atom; b) a linear C1-C6 or branched C3-C6 saturated alkyl group; preferably, the compounds of formula (I) and the tautomer (!) or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or as a mixture; have the following meanings: - Ri of formula (I) and (!') represents a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C4 or branched C3-C4 alkyl group optionally substituted by one or more groups, which may be the same or different, chosen from i) -OR3>more preferably unsubstituted; - R2 of formula (I) and (!') represents a radical chosen from: a) a hydrogen atom; (b) a linear C1-C10 or branched C3-C10 or cyclic C3-C8 such as C5-C6 saturated hydrocarbon group, optionally substituted by one or more groups, which may be the same or different, chosen from: i) -O-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group, optionally substituted with one or several hydroxyls and / or by one or more C1-C4 alkoxy radicals - R3 of formula (I) and (I1) represents a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C4 or branched C3-C4 alkyl group such as methyl or ethyl.
6. Biphasic composition according to any one of the preceding claims, wherein the compound of formula (I) selected from the group consisting of compounds 1 to 24 below and their tautomer or their salts, their optical isomers, racemates and / or solvates such as hydrates, alone or in mixture, particularly compounds 1, 2, 4, 6, 7, 9, 11, 12, 14, 15, 16, 17, 18, 19, 20 or 21, more particularly 1, 9, 16, 18, 19, 20 or 21, preferentially 18, 19, 20 or 21, more preferentially 20: No. Structure Chemical name .■s [ï § * N-étiyl-2-îhtoxo-1,2-d^ydf epynciîne-3- 2 XZ \XX / XX 11111 'S 3 4 ...
1. ... l'T ¥ •\ x;--' V; '' x >' There is no 5 .-.......X ■ XX-.....X 'XX? X,....... / - x X N-phény§-2-^raxû-1 SO % x „..xx  J ^24hmxa-i .2-^Wdropyfkfôie-3-ï^a^cucte I- N^^-mêlhcxy^éi^l^MF'2ï'?ré'^0^ctënh0' 5. i 1' y )SH2Hnélhy$)fopÿ^^^ î ,2-dfeydropÓdine<3-ssFtxKa^^^ 9 X .. X. ..-> ..-V, .CK' (X. w 1 i| a N-nony^2-1ftK)xo-12-àh^ '^MÉ 11 N-<2-hy* Gÿy éthy SJ-2-ïhiocci-12-d8hy <lr>pyndme-3-£arboxæni <Se 12 ..Z*. Z'1^. , S*, N 2-merta 13 :'■ x / .....v v ..-¼. \ '’7f 's N-^^-f24sydràxyèWÎ> 2-85or-1,2-. <ghÿàropyï»e<^€afb^^ 14 Xx<‘' '■> <■'' Ns-"'* N->;2;y®ÿ(fraxypropy^^^^ dSydrapywtoe-3-œr^^ 15 H-(1..^hydroxÿpropan-2-^ dshydK>pyn(toe-3-carto^^ 15 z”'- H"'( -2^'«'' 2Hayds'spyÆi^-3-^ 18 ... 1 „ ( 'X x T ■■ ■ i - aitonyl^O^ $ W K-[{24fàoxs-1r2-dY 20 Cx':'v N-{ï2-^k^s-1.2? d jhydfqjyridi^3-y Gtylly ca»2ÿÿjO No«^Yg2-^ifixs-12^ 4*y1)ca <égnyî]5^œe 22 . t o.....r... ÿ << ■ n, k-§i§(2-hydfo:<yê^^^ ,2- djhydropyïtàme-3-^fbqxamtâ^ 23 j il s yt^ (m3-n^<wfwt}-2-tjtex8-1,2-.djhydrapyri£^e-3-cartra^24 XX x - -if tf -■ Y *
7. A biphasic composition according to any preceding claim, wherein the oil-soluble / dispersible active agent is selected from the group consisting of retinoids, vitamin D, vitamin E, vitamin K, phenylethyl resorcinol or its derivative, such as an ester or a hydrophobic modification thereof, and mixtures thereof, more preferably the oil soluble / dispersible active agent is selected from the group consisting of retinoids.
8. Two-phase composition according to any one of the preceding claims, wherein the hydrophobic particles C) are selected from the group consisting of starches, talcs, silicone resin powders, hollow hemispherical silicone particles, hydrophobic celluloses and their derivatives, hydrophobic silicas, polyamide powders, hydrophobic pigments or their mixture; preferentially selected from the group consisting of starches, hydrophobic celluloses and their derivatives, hydrophobic silicas, or their mixtures; more preferentially, selected from ethylcellulose, silica dimethylsilylate, or their mixture.
9. Use of the two-phase composition according to any one of the preceding claims for the care of keratinous materials.
10. Process for caring for keratinous materials, comprising applying the two-phase composition according to any one of claims 1 to 8 to the keratinous materials. < / lr>
Citation Information
Patent Citations
Process for depigmenting keratin materials using thiopyridinone compounds
EP3390363A1
COMPOSITION FOR THE CARE OF KERATINOUS MATERIALS
FR3117845A1
Composition of pickering emulsion comprising low amount of alcohol
WO2015089750A1
Sprayable sunscreen composition with oil beads
WO2016008121A1
Use of thiopyridinone compounds for preventing the formation of cutaneous blackheads
WO2022079122A1
